Osteoporosis International

, Volume 19, Issue 1, pp 79–86

The care gap in diagnosis and treatment of women with a fragility fracture

Authors

    • Laval University, Rheumatology and Immunology Research Centre, CHUL Research Centre
  • L.-G. Ste-Marie
    • University of Montreal, Department of Medicine, Centre de recherche du CHUM, Hôpital Saint-Luc
  • S. Jean
    • Institut national de santé publique du Québec
  • K. S. Davison
    • Laval University, Rheumatology and Immunology Research Centre, CHUL Research Centre
  • M. Beaulieu
    • Patient Health ManagementMerck Frosst Canada Ltd
  • M. Baranci
    • Sanofi-aventis Canada Inc
  • J. Bessant
    • P&G Pharmaceuticals Canada Inc
  • J. P. Brown
    • Laval University, Rheumatology and Immunology Research Centre, CHUL Research Centre
Original Article

DOI: 10.1007/s00198-007-0426-9

Cite this article as:
Bessette, L., Ste-Marie, L., Jean, S. et al. Osteoporos Int (2008) 19: 79. doi:10.1007/s00198-007-0426-9

Abstract

Summary

In women aged 50 years or more who experienced a fracture, 81% suffered a fragility fracture. Six to eight months after fragility fracture, 79% had either not been investigated for osteoporosis or prescribed anti-fracture therapy. Despite fragility fractures being common in this population osteoporosis is under-diagnosed and under-treated.

Introduction

The objective of this study was to evaluate the diagnostic and treatment rates for osteoporosis six months following fragility fracture.

Methods

This prospective cohort study was set in the general community from the Province of Quebec, Canada. Women at least 50 years of age who suffered a fracture were recruited during their initial visit to the hospital and had their fracture type classified as either fragility or traumatic. Six-to-eight months after fragility fracture, women were again contacted to evaluate the diagnostic and treatment rates of osteoporosis.

Results

Of the 2,075 women recruited over a 25 month period 1688 (81%) sustained a fragility fracture and 387 (19%) sustained a traumatic fracture. Nine hundred and three participants with a fragility fracture were again contacted six-to-eight months after fracture. For the 739 women not on treatment on the recruitment day, only 15.4% initiated pharmacological therapy in the six-to-eight-month period following fracture and 79.0% had either not been investigated for osteoporosis or prescribed anti-fracture treatment.

Conclusions

The proportion of fragility fractures to total fractures is higher than previously reported. Despite the availability of diagnostic modalities, effective treatments, and adequate health care assessments, there is a substantial care gap in the management of osteoporosis.

Keywords

Care gapDiagnosisFragility fractureOsteoporosisTreatment

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007